Sep 25, 2012
By:
Archie Lovatt, PhD, SGS Life Science Services
Regulatory authorities impose stringent limits on the amount of microbial contaminate and impurities present during the manufacturing of biological medicines and all components of the process must undergo safety testing.
|
Avoid manufacturing failures by effective viral inactivation.
Oct 1, 2008
By:
Raymond W. Nims, PhD, Sandra K. Dusing, PhD, Wang-Ting Hsieh, PhD, Archie Lovatt, PhD, G. Gordon Reid, PhD, David Onions, PhD, FRSE, Euan W. Milne
Avoid manufacturing failures by effective viral inactivation.
|
|
